<DOC>
	<DOC>NCT02929628</DOC>
	<brief_summary>Patients with an implantable electrical nerve stimulation system Patient criteria included: over 18 years of age,MMSE≥ 24 score; H-Y stage in medicine off condition＞2.0;an ability to walk at least 10 meters independently;subscore≥2 for UPDRS part II item 15;subscore ＞1 for UPDRS part II item 14; permissions given by informed consent. Patients with serious diseases such as tumor, sever liver or kidney dysfunction were not selected in the clinical trials. Subjects participating in other clinical trials related or not related to these trials were not chosen.</brief_summary>
	<brief_title>Evaluate the Safety and Effectiveness of Various Frequency Stimulation for Patients With Parkinson's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Age ＞18 years of age,male or female patients idiopathic Parkinson's disease had deep brain stimulaton implant HY＞2.0 in the absence of Ldopa UPDRSII14 item ≥1 UPDRSII15 item ≥2 an ability to walk at least 10 meters independently Patients with serious diseases such as tumor, sever liver or kidney dysfunction were not selected in the clinical trials epilepsy Pregnant female History of severe neuropsychiatric disease Patients are taking part in other clinical trials in recent several months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>